l carnitine tmao koeth 2013 nature medicine JCI γ-Butyrobetaine Is a Proatherogenic Intermediate
Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L Carnitine to TMAO: Cell Metabolism The gutbrain axis and trimethylamine N oxide: an emergent biomarker in neurological diseases ScienceDirect Characterization of TMAO productivity from carnitine challenge facilitates personalized nutrition and microbiome signatures discovery Microbiome Springer Nature Link Dietary allicin reduces transformation of L carnitine to TMAO through impact on gut microbiota ScienceDirect
Pay in 4 interest-free payments of $6.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24



